Rajasthan health dept rules out govt cough syrup link in child deaths

Public Health Director Ravi Prakash Sharma said inquiry reports confirmed that in both cases, the children were administered the syrup at home without a doctor's advice

cough syrup, medicine, cold
As per protocol, Dextromethorphan (DXM) drug is not prescribed to children, Sharma said in the statement released on Thursday and added that in both incidents, the doctors had not prescribed the drug. Photo: Shutterstock
Press Trust of India Jaipur
2 min read Last Updated : Oct 02 2025 | 10:44 PM IST

The Rajasthan Health Department has clarified that the recent deaths of two children in Bharatpur and Sikar districts were not caused by cough syrup distributed under the state's free medicine scheme, according to an official statement.

Public Health Director Ravi Prakash Sharma said inquiry reports confirmed that in both cases, the children were administered the syrup at home without a doctor's advice.

As per protocol, Dextromethorphan (DXM) drug is not prescribed to children, Sharma said in the statement released on Thursday and added that in both incidents, the doctors had not prescribed the drug.

Health Minister Gajendra Singh had earlier ordered a probe into the matter after reports of poor-quality cough syrup surfaced.

Following the order, the Rajasthan Medical Services Corporation Limited (RMSCL) halted the supply and use of the drug, formed a three-member inquiry committee and sent some samples for testing at the state drug laboratory.

However, in another case from Sikar, a child was wrongly prescribed a cough syrup containing the drug DXM. Subsequently, the Health Department initiated suspension proceedings against the doctor and pharmacist concerned for violating protocol.

The department has also issued an advisory directing doctors to strictly follow prescription protocols and ensure medicines are dispensed only against prescriptions. It also urged the public not to take medicines without medical advice.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :India NewsrajasthanchildrenCough syrup

First Published: Oct 02 2025 | 10:44 PM IST

Next Story